Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans

被引:54
作者
Langberg, H [1 ]
Boushel, R
Skovgaard, D
Risum, N
Kjær, M
机构
[1] Copenhagen Univ Hosp Bispebjerg, Sports Med Res Unit, Dept Rheumatol, DK-2400 Copenhagen NV, Denmark
[2] Concordia Univ, Dept Exercise Physiol, Montreal, PQ, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2003年 / 551卷 / 02期
关键词
D O I
10.1113/jphysiol.2003.046094
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mechanical loading is known to increase connective tissue blood flow of human tendons and to cause local release of vasodilatory substances. The present study investigated the importance of prostaglandins (PG) formed by cyclo-oxygenase isoforms (COX- 1 and 2) for the exercise-related increase in blood flow in connective tissue. Healthy individuals (n = 24, age: 23-31 years) underwent 30 min of intermittent, isometric, plantarflexion with both calf muscles either without (n = 6, Control, Q or with blockade of PG formation, either COX-2 specific (n = 10, Celecoxib 2 x 100 mg day(-1) for 3 days prior to the experiment) or COX unspecific (n = 8, indomethacin 100 mg (12 and 1 h pre-experiment) and acetyl salicylic acid 500 mg day(-1) for 3 days pre-experiment). Prostaglandin E-2 (PGE(2)) concentration was determined by microdialysis and blood flow by Xe-133 washout. In C, interstitial PGE(2) rose from (0.8 +/- 0.2 (rest) to 1.4 +/- 0.5 ng ml(-1) (exercise), P < 0.05), whereas during unspecific COX inhibition, tissue PGE(2) was completely inhibited at rest and during exercise. COX-2 specific blockade did not inhibit tissue PGE(2) at rest, but totally abolished the exercise induced increase. Blood flow was similar in the three groups at rest (P > 0.05), whereas the increase in flow with exercise was reduced by 35 and 43 % with COX-2 specific blockade (3.2 +/- 0.7 to 6.1 +/- 1.5 ml (100 g tissue)(-1) min(-1) or COX unspecific blockade (3.0 +/- 0.8 to 7.6 +/- 1.6), respectively, compared to C (2.7 +/- 0.8 to 10.2 +/- 2.0) (P < 0.05). The findings indicate that COX-2 specific mechanisms are responsible for the exercise-induced increase in prostaglandin synthesis, and that increase in tissue prostaglandin plays an important role for blood flow in peritendinous connective tissue during physical loading in vivo.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 45 条
[1]   SEGMENTAL VARIATION IN MICROSTRUCTURE, MATRIX SYNTHESIS AND CELL-PROLIFERATION IN RABBIT FLEXOR TENDON [J].
ABRAHAMSSON, SO ;
LUNDBORG, G ;
LOHMANDER, LS .
SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 1989, 23 (03) :191-198
[2]  
Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96
[3]   In situ microdialysis in tendon tissue:: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain [J].
Alfredson, H ;
Thorsen, K ;
Lorentzon, R .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 1999, 7 (06) :378-381
[4]   In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper's knee [J].
Alfredson, H ;
Forsgren, S ;
Thorsen, K ;
Lorentzon, R .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, 19 (05) :881-886
[5]   Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis [J].
Anderson, GD ;
Hauser, SD ;
McGarity, KL ;
Bremer, ME ;
Isakson, PC ;
Gregory, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2672-2679
[6]  
ASTROM M, 1994, CLIN ORTHOP RELAT R, P166
[7]  
ASTROM M, 1995, CLIN ORTHOP RELAT R, P151
[8]   Nociception in cyclooxygenase isozyme-deficient mice [J].
Ballou, LR ;
Botting, RM ;
Goorha, S ;
Zhang, JY ;
Vane, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10272-10276
[9]   Blood flow and oxygenation in peritendinous tissue and calf muscle during dynamic exercise in humans [J].
Boushel, R ;
Langberg, H ;
Green, S ;
Skovgaard, D ;
Bülow, J ;
Kjær, M .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 524 (01) :305-313
[10]  
Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735